What is Advarra?
Advarra is a pivotal player in the life sciences sector, dedicated to transforming clinical research through a synergistic approach to safety, technology, and collaboration. The company unites life sciences firms, Contract Research Organizations (CROs), research institutions, investigators, and academic bodies. By leveraging trusted review solutions, cutting-edge technologies, expert consultancy, and extensive industry networks, Advarra delivers comprehensive solutions. These offerings are crucial for safeguarding trial participants, bolstering the capabilities of clinical sites, ensuring regulatory compliance, and maximizing research efficiency, ultimately making clinical trials safer, smarter, and faster.
How much funding has Advarra raised?
Advarra has raised a total of $1.8B across 1 funding round:
Debt
$1.8B
Debt (2022): $1.8B with participation from Genstar Capital
Key Investors in Advarra
Genstar Capital
Genstar Capital is a prominent private equity firm specializing in the middle market, with a strategic focus on high-quality companies across financial services, software, industrials, and healthcare. They partner with management teams to drive growth and transformation, offering capital alongside operational guidance and strategic insight to build enduring businesses.
What's next for Advarra?
The recent major strategic investment positions Advarra for accelerated growth and further innovation in the clinical research technology and services space. This significant capital infusion is expected to fuel the expansion of its integrated solutions, potentially leading to enhanced technological capabilities and broader market reach. Advarra's focus on optimizing research performance and ensuring participant safety aligns with the increasing demands for efficiency and integrity in clinical trials, suggesting a trajectory of continued leadership and strategic development within the industry.
See full Advarra company page
